Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (14002)
All Articles published online
|
Publishing Process of This Article
|
Sep 14, 2019 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yang JM, Sun Y, Wang M, Zhang XL, Zhang SJ, Gao YS, Chen L, Wu MY, Zhou L, Zhou YM, Wang Y, Zheng FJ, Li YH. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease. World J Gastroenterol 2019; 25(34): 5105-5119 [PMID: 31558860 DOI: 10.3748/wjg.v25.i34.5105] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i34/5105.htm |
| Number | Citing Articles |
| 1 |
Yuan Ma, Kewei Sun, Jianzhong Cao, Xiaowu Qin, Jiaoling Shi, Huiying Li, Jun Zhang, Tao Zhang. Acupuncture combined with Chinese herbal medicine on non-alcoholic fatty liver disease. Medicine 2021; 100(51): e28083 doi: 10.1097/MD.0000000000028083
|
| 2 |
Fangqing Zhang, Jiashuo Wu, Haonan Ruan, Jing Xia, Haotian Xue, Jingxun Wang, Qiuyue Li, Yue Shi. ZeXie decoction alleviates non-alcoholic fatty liver disease in rats: the study of genes, lipids, and gut microbiotas. Biochemical and Biophysical Research Communications 2022; 632: 129 doi: 10.1016/j.bbrc.2022.09.097
|
| 3 |
Ruolei Wang, Fengjing Jia, Zhenguo Zhao, Liqing Du, Lianheng Lu, Dongkui Xu, Feng He. Dachaihu decoction inhibits hypernutrition-induced liver metastasis from colorectal cancer by maintaining the gut vascular barrier. Cancer Pathogenesis and Therapy 2023; 1(2): 98 doi: 10.1016/j.cpt.2023.02.003
|
| 4 |
Haijiao Shi, Miao Sun, Shuai Wang, Fanyu He, Ronglai Yang, Zheng Li, Wei Chen, Fengrong Wang. Jiawei Dachaihu decoction protects against mitochondrial dysfunction in atherosclerosis (AS) mice with chronic unpredictable mild stress (CUMS) via SIRT1/PGC-1α/TFAM/LON signaling pathway. Journal of Ethnopharmacology 2024; 330: 118150 doi: 10.1016/j.jep.2024.118150
|
| 5 |
Zhaolin Sun, Yuhua Wei, Yuchen Xu, Jianwei Jiao, Xiuying Duan. The use of traditional Chinese medicine in the treatment of non-alcoholic fatty liver disease: A review. Pharmacological Research - Modern Chinese Medicine 2024; 12: 100475 doi: 10.1016/j.prmcm.2024.100475
|
| 6 |
Juan Li, Qian Hu, Dai Xiao-yu, Lv Zhu, Yi-fan Miao, Hong-xin Kang, Xian-lin Zhao, Jia-qi Yao, Dan Long, Wen-fu Tang, Mei-hua Wan, Hongwei Zhang. Effect of Sheng‐Jiang Powder on Gut Microbiota in High‐Fat Diet‐Induced NAFLD. Evidence-Based Complementary and Alternative Medicine 2020; 2020(1) doi: 10.1155/2020/6697638
|
| 7 |
Jian Sun, Yan Chen, Tao Wang, Waseem Ali, Yonggang Ma, Yan Yuan, Jianhong Gu, Jianchun Bian, Zongping Liu, Hui Zou. Baicalin and N-acetylcysteine regulate choline metabolism via TFAM to attenuate cadmium-induced liver fibrosis. Phytomedicine 2024; 125: 155337 doi: 10.1016/j.phymed.2024.155337
|
| 8 |
Yang Hai, Ling Zuo, Meng Wang, Ruoyu Zhang, Munan Wang, Li Ren, Congwen Yang, Jianwei Wang. Icariin Alleviates Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome by Improving Liver Fatty Acid Oxidation and Inhibiting Lipid Accumulation. Molecules 2023; 28(2): 517 doi: 10.3390/molecules28020517
|
| 9 |
Hongkun Xue, Yu Wang, Hongwei Xiang, Qi Song, Guowei Zhang, Jianguo Wang, Shaoqin Ge, Rajeev K Singla. Exploring the Protective Effects and Mechanism of Huaji Jianpi Decoction against Nonalcoholic Fatty Liver Disease by Network Pharmacology and Experimental Validation. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/5440347
|
| 10 |
De-Shan Ning, Yu-Ju Chen, Chien-Ju Lin, Ching-Chiung Wang, Hong-Wei Zhao, Kun-Teng Wang, Ming-Chung Lee, Lemmuel L. Tayo, Wan-Chun Chiu, Chiu-Li Yeh, Chia-Jung Lee. Hepatoprotective effect of botanical drug formula on high-fat diet-induced non-alcoholic fatty liver disease by inhibiting lipogenesis and promoting anti-oxidation. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1026912
|
| 11 |
Yun-Mi Kang, Kwang-Youn Kim, Tae In Kim, Yeon-Ji Kim, Han-Hae Kim, Kyungho Kim. Cheong-sang-bang-pung-san alleviated hepatic lipid accumulation by regulating lipid metabolism in vitro and in vivo. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1223534
|
| 12 |
Zhi-wei Liu, Yi-ming Zhang, Li-ying Zhang, Ting Zhou, Yang-yang Li, Gu-cheng Zhou, Zhi-ming Miao, Ming Shang, Jin-peng He, Nan- Ding, Yong-qi Liu. Duality of Interactions Between TGF-β and TNF-α During Tumor Formation. Frontiers in Immunology 2022; 12 doi: 10.3389/fimmu.2021.810286
|
| 13 |
Bin-Sheng Wang, Chen-Li Zhang, Xiang Cui, Qiang Li, Lei Yang, Zhi-Yun He, Ze Yang, Miao-Miao Zeng, Nong Cao. Curcumin inhibits the growth and invasion of gastric cancer by regulating long noncoding RNA AC022424.2. World Journal of Gastrointestinal Oncology 2024; 16(4): 1437-1452 doi: 10.4251/wjgo.v16.i4.1437
|
| 14 |
Sha Li, Yu Xu, Wei Guo, Feiyu Chen, Cheng Zhang, Hor Yue Tan, Ning Wang, Yibin Feng. The Impacts of Herbal Medicines and Natural Products on Regulating the Hepatic Lipid Metabolism. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00351
|
| 15 |
Qiang Chen, Xinru Chen, Yuqing Zhu, Xiali Yu. A relatively rare traditional Chinese medicine pattern of primary Sjögren syndrome: A case report. Medicine 2024; 103(15): e37744 doi: 10.1097/MD.0000000000037744
|
| 16 |
Hui Han, Yi Jiang, Mengyu Wang, Mebratu Melaku, Lei Liu, Yong Zhao, Nadia Everaert, Bao Yi, Hongfu Zhang. Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): focusing on the gut–liver axis. Critical Reviews in Food Science and Nutrition 2023; 63(12): 1689 doi: 10.1080/10408398.2021.1966738
|
| 17 |
Bin Cheng, Ai-Zhen Zhou, Wen Ge, Xiao-Min Yao, Juan Wang, Daniel Dias Rufino Arcanjo. Mechanism of Huo-Xue-Qu-Yu Formula in Treating Nonalcoholic Hepatic Steatosis by Regulating Lipid Metabolism and Oxidative Stress in Rats. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/6026319
|
| 18 |
Longshan Ji, Qian Li, Yong He, Xin Zhang, Zhenhua Zhou, Yating Gao, Miao Fang, Zhuo Yu, Robim M. Rodrigues, Yueqiu Gao, Man Li. Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD: A promising drug Potentilla discolor Bunge. Acta Pharmaceutica Sinica B 2022; 12(9): 3529 doi: 10.1016/j.apsb.2022.05.001
|
| 19 |
Esraa M. Zakariaª, Rasha H. Abdel-Ghanyª, Atef S. Elgharbawyª, Amira Ebrahim Alsemehᵇ, Sami S. Metwallyª. A novel approach to repositioning memantine for metabolic syndrome-induced steatohepatitis: Modulation of hepatic autophagy, inflammation, and fibrosis. Life Sciences 2023; 319: 121509 doi: 10.1016/j.lfs.2023.121509
|
| 20 |
Xue Tian, Xingyue Wang, Wei Xu, Meng Gong, Chuanyuan Zhou, Ercheng Jiang, Yongqing Tang, Lirong Jia, Li Zeng, Sha Deng, Feixia Duan. Penthorum chinense Pursh leaf tea debittering mechanisms via green tea manufacturing process and its influence on NAFLD-alleviation activities. Food Chemistry 2024; 445: 138715 doi: 10.1016/j.foodchem.2024.138715
|
| 21 |
Wenya Meng, Zitong Zhao, Lingli Chen, Suyun Lin, Yang Zhang, Jing He, Kehui Ouyang, Wenjun Wang. Total Flavonoids from Chimonanthus nitens Oliv. Leaves Ameliorate HFD-Induced NAFLD by Regulating the Gut–Liver Axis in Mice. Foods 2022; 11(14): 2169 doi: 10.3390/foods11142169
|
| 22 |
Khaled M. M. Koriem. A Review on Radix Scutellariae: A Traditional Chinese Medicine with Great Medicinal Significant. World Journal of Traditional Chinese Medicine 2024; 10(3): 284 doi: 10.4103/2311-8571.392881
|
| 23 |
Tuğba Çelik Samancı, Alpaslan Gökçimen, Tuncay Kuloğlu, Murat Boyacıoğlu, Yurdun Kuyucu, Sait Polat. Biochemical and Histopathological Investigation of Liver Tissues on High Fat Diet Fed Rats. Meandros Medical and Dental Journal 2022; 23(1): 101 doi: 10.4274/meandros.galenos.2021.32932
|
| 24 |
Yuqi Ying, Haitao Zhang, Dian Yu, Wei Zhang, Dongling Zhou, Shuangchun Liu, Vincenzo De Feo. Gegen Qinlian Decoction Ameliorates Nonalcoholic Fatty Liver Disease in Rats via Oxidative Stress, Inflammation, and the NLRP3 Signal Axis. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/6659445
|
| 25 |
Li Xu, Hongliang Cui. Yinchenhao Tang alleviates high fat diet induced NAFLD by increasing NR1H4 and APOA1 expression. Journal of Traditional and Complementary Medicine 2023; 13(4): 325 doi: 10.1016/j.jtcme.2023.02.010
|
| 26 |
Ana Mara de Oliveira e Silva, Raquel Oliveira Pereira, Anne Karoline de Souza Oliveira, Fernanda Santana Harris, Illana Louise Pereira de Melo, Thiago Henrique Almeida-Souza, Luciana Tedesco Yoshime, Caroline dos Santos Melo, Jymmys Lopes dos Santos, Elma Regina Silva de Andrade-Wartha, Bruno Cogliati, Daniel Granato, Jorge Mancini-Filho. Ameliorative effects of aqueous extract from rosemary on oxidative stress and inflammation pathways caused by a high-fat diet in C57BL/6 mice. Applied Physiology, Nutrition, and Metabolism 2024; 49(4): 459 doi: 10.1139/apnm-2023-0157
|
| 27 |
Kareem M Abdelraheem, Nahla N Younis, Mohamed A Shaheen, Sahar E Elswefy, Sousou I Ali. Raspberry ketone improves non-alcoholic fatty liver disease induced in rats by modulating sphingosine kinase/sphingosine-1-phosphate and toll-like receptor 4 pathways. Journal of Pharmacy and Pharmacology 2023; 75(7): 985 doi: 10.1093/jpp/rgad044
|
| 28 |
Haoqu Tan, Jinfang Hu, Wei Zuo, Yun Huang, Jian Cui, Fei Gong, Wei Bai. Loss of RAGE prevents chronic intermittent hypoxia-induced nonalcoholic fatty liver disease via blockade of NF-кB pathway. Gene Therapy 2023; 30(3-4): 278 doi: 10.1038/s41434-022-00351-4
|
| 29 |
Fang-Fang Zhuo, Xiao-Qing Li, Jun Zhang, Fu-Ming Zhang, Zhao-Hui Song, Yi He, Li Ding, Dan Liu, Peng-Fei Tu, Xiao-Hui Ma, Ke-Wu Zeng. Total glucosides of Picrorhizae Rhizome alleviate non-alcoholic steatohepatitis (NASH) by specifically targeting acyl-CoA oxidase 1. Heliyon 2024; 10(21): e39874 doi: 10.1016/j.heliyon.2024.e39874
|
| 30 |
Jian-Hong Ding, Zhe Jin, Xiao-Xu Yang, Jun Lou, Wei-Xi Shan, Yan-Xia Hu, Qian Du, Qiu-Shi Liao, Rui Xie, Jing-Yu Xu. Role of gut microbiota via the gut-liver-brain axis in digestive diseases. World Journal of Gastroenterology 2020; 26(40): 6141-6162 doi: 10.3748/wjg.v26.i40.6141
|
| 31 |
Xiang Chen, Menghan Liu, Jun Tang, Ning Wang, Yibin Feng, Haotian Ma. Research Progress on the Therapeutic Effect of Polysaccharides on Non-Alcoholic Fatty Liver Disease through the Regulation of the Gut–Liver Axis. International Journal of Molecular Sciences 2022; 23(19): 11710 doi: 10.3390/ijms231911710
|
| 32 |
Jinliang Du, Li-ping Cao, Rui Jia, Zhengyan Gu, Qin He, Pao Xu, Guojun Yin, Yuzhong Ma. Alleviative effects of total flavones of Glycyrrhiza uralensis Fisch on oxidative stress and lipid metabolism disorder induced by high-fat diet in intestines of Tilapia (Oreochromis niloticus). 3 Biotech 2021; 11(7) doi: 10.1007/s13205-021-02785-w
|
| 33 |
Huilian Shi, Yanliang Zhang, Jing Xing, Lina Liu, Fei Qiao, Jun Li, Yuanyuan Chen. Baicalin attenuates hepatic injury in non-alcoholic steatohepatitis cell model by suppressing inflammasome-dependent GSDMD-mediated cell pyroptosis. International Immunopharmacology 2020; 81: 106195 doi: 10.1016/j.intimp.2020.106195
|
| 34 |
Yanqi Dang, Jingjuan Xu, Yang Yang, Chunlin Li, Qiang Zhang, Wenjun Zhou, Li Zhang, Guang Ji. Ling-gui-zhu-gan decoction alleviates hepatic steatosis through SOCS2 modification by N6-methyladenosine. Biomedicine & Pharmacotherapy 2020; 127: 109976 doi: 10.1016/j.biopha.2020.109976
|
| 35 |
Yuqiao Liu, Yue Fan, Jibin Liu, Xiyang Liu, Xiuyan Li, Jingqing Hu. Application and mechanism of Chinese herb medicine in the treatment of non-alcoholic fatty liver disease. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1499602
|
| 36 |
Zhiqing Mou, Tao Gong, Yanzuo Wu, Jun Liu, Jianhua Yu, Lichan Mao. The efficacy and safety of Dachaihu decoction in the treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1397900
|
| 37 |
Shaojie Huang, Fei Mu, Fei Li, Wenjun Wang, Haixia Chen, Lu Lei, Yang Ma, Yi Ding, Jingwen Wang. A Network-Based Approach to Explore the Mechanism and Bioactive Compounds of Erzhi Pill against Metabolic Dysfunction-Associated Fatty Liver Disease. Journal of Diabetes Research 2020; 2020: 1 doi: 10.1155/2020/7867245
|
| 38 |
Baifei Hu, Huabing Yang, Guangming Chen, Xiongjie Sun, Xiaojuan Zou, Jun Ma, Xiaowei Yao, Qiong Liang, Hongtao Liu. Structural characterization and preventive effect on non-alcoholic fatty liver disease of oligosaccharides from Bletilla striata. Food & Function 2022; 13(8): 4757 doi: 10.1039/D1FO03899K
|
| 39 |
Yanan Xue, Yue Wei, Lan Cao, Min Shi, Junqing Sheng, Qin Xiao, Ziwen Cheng, Tao Luo, Quanhui Jiao, Ailan Wu, Chen Chen, Lingyun Zhong, Changhua Zhang. Protective effects of scutellaria-coptis herb couple against non-alcoholic steatohepatitis via activating NRF2 and FXR pathways in vivo and in vitro. Journal of Ethnopharmacology 2024; 318: 116933 doi: 10.1016/j.jep.2023.116933
|
| 40 |
Tingwei Wang, Yongli Ye, Jian Ji, Xingxing Yang, Jiayuan Xu, Jia-Sheng Wang, Xiaomin Han, Ting Zhang, Xiulan Sun. Diet composition affects long-term zearalenone exposure on the gut–blood–liver axis metabolic dysfunction in mice. Ecotoxicology and Environmental Safety 2022; 236: 113466 doi: 10.1016/j.ecoenv.2022.113466
|
| 41 |
Yuanfang Sun, Leqi Wang, Lijing Du, Huajun Yu, Yan Tian, Huizi Jin, Shasha Li, Shikai Yan, Xue Xiao. Investigation on the mechanism of Ginkgo Folium in the treatment of Non-alcoholic Fatty Liver Disease by strategy of network pharmacology and molecular docking. Technology and Health Care 2023; 31: 209 doi: 10.3233/THC-236018
|
| 42 |
Miao Shen, Hanghai Pan, Jinjing Ke, Fei Zhao. NF‐κB‐upregulated miR‐155‐5p promotes hepatocyte mitochondrial dysfunction to accelerate the development of nonalcoholic fatty liver disease through downregulation of STC1. Journal of Biochemical and Molecular Toxicology 2022; 36(6) doi: 10.1002/jbt.23025
|
| 43 |
Jie Ni, Chen Chen, Jiake Tang, Siqi Hu, Yao You, Shenghui Zhang, Jingjie Jiang, Chunyi Wang, Wen Wen, Xingwei Zhang, Mingwei Wang. Effects of Shenxiang Suhe Pill on coronary heart disease complicated with nonalcoholic fatty liver disease: A case–control study. Medicine 2022; 101(49): e31525 doi: 10.1097/MD.0000000000031525
|
| 44 |
Zehua Zhang, Yulin Leng, Xiaoxu Fu, Chan Yang, Hongyan Xie, Haipo Yuan, Qingzhi Liang, Hong Gao, Chunguang Xie. The efficacy and safety of dachaihu decoction in the treatment of type 2 diabetes mellitus: A systematic review and meta-analysis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.918681
|
| 45 |
Tingting Liu, Guang Xu, Longxin Liang, Xiaohe Xiao, Yanling Zhao, Zhaofang Bai. Pharmacological effects of Chinese medicine modulating NLRP3 inflammasomes in fatty liver treatment. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.967594
|
| 46 |
Shuzhou Wang, Haihua Huo, Haitong Wu, Feiyang Ma, Jianzhao Liao, Xinrun Li, Qingyu Ding, Zhaoxin Tang, Jianying Guo. Effects of NAC assisted insulin on cholesterol metabolism disorders in canine type 1 diabetes mellitus. Life Sciences 2023; 313: 121193 doi: 10.1016/j.lfs.2022.121193
|
| 47 |
Xia Wu, Yurong Zhang, Ding Zheng, Yue Yin, Mengyun Peng, Jing Wang, Xiaoning Zhu. Prediction of the mechanisms of action of Qutan Huoxue decoction in non-alcoholic steatohepatitis (NASH): a network pharmacology study and experimental validation. Pharmaceutical Biology 2023; 61(1): 520 doi: 10.1080/13880209.2023.2182892
|
| 48 |
Meng Zhang, Yuan Yuan, Wenjing Zhou, Yali Qin, Kaixia Xu, Jiuzhang Men, Mingxin Lin. Network pharmacology analysis of Chaihu Lizhong Tang treating non-alcoholic fatty liver disease. Computational Biology and Chemistry 2020; 86: 107248 doi: 10.1016/j.compbiolchem.2020.107248
|
| 49 |
Feng Jiarun, Wei Xiaoqian, Chen Jieru, Wang Zirui, Lu Li, Lin Xiukun, Jiang Mengxi, Bauer Rudolf, Xu Huanli. Modulatory effects and structural alteration of gut microbiota by traditional Chinese medicine. Pharmacological Research - Modern Chinese Medicine 2022; 5: 100200 doi: 10.1016/j.prmcm.2022.100200
|
| 50 |
Han Chen, Ye Yao, Wenbo Wang, Dongsheng Wang, Daniel Dias Rufino Arcanjo. Ge-Gen-Jiao-Tai-Wan Affects Type 2 Diabetic Rats by Regulating Gut Microbiota and Primary Bile Acids. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/5585952
|
| 51 |
Yuhan Cao, Jingying Shi, Luyao Song, Junjiu Xu, Henglei Lu, Jianhua Sun, Jinjun Hou, Jing Chen, Wanying Wu, Likun Gong. Multi-Omics Integration Analysis Identifies Lipid Disorder of a Non-Alcoholic Fatty Liver Disease (NAFLD) Mouse Model Improved by Zexie–Baizhu Decoction. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.858795
|
| 52 |
Waleed Alghamdi, Mahmoud Mosli, Saleh A. Alqahtani. Gut microbiota in MAFLD: therapeutic and diagnostic implications. Therapeutic Advances in Endocrinology and Metabolism 2024; 15 doi: 10.1177/20420188241242937
|
| 53 |
Supriyo Ghosh, Amlan Jyoti Ghosh, Rejuan Islam, Sagar Sarkar, Tilak Saha, Ahmed Khalafallah Sadeq Rashwan. Lactobacillus plantarum KAD protects against high-fat diet-induced hepatic complications in Swiss albino mice: Role of inflammation and gut integrity. PLOS ONE 2024; 19(11): e0313548 doi: 10.1371/journal.pone.0313548
|
| 54 |
Tongtong Li, Dongcan Tian, Mengtian Lu, Bijiao Wang, Jun Li, Baohua Xu, Hao Chen, Shijin Wu. Gut microbiota dysbiosis induced by polychlorinated biphenyl 126 contributes to increased brain proinflammatory cytokines: Landscapes from the gut-brain axis and fecal microbiota transplantation. Ecotoxicology and Environmental Safety 2022; 241: 113726 doi: 10.1016/j.ecoenv.2022.113726
|
| 55 |
Zhi-Hui Guo, Hui-Ying Ni, Meng-Ya Tang. Clinical efficacy and pharmacological mechanism analysis of Xubi Capsule in the treatment of patients with liver and kidney deficiency osteoarthritis. Medicine 2024; 103(35): e39327 doi: 10.1097/MD.0000000000039327
|
| 56 |
Jiashuo Wu, Fangqing Zhang, Haonan Ruan, Xiaoyan Chang, Jingxun Wang, Zhuangzhuang Li, Weiyi Jin, Yue Shi. Integrating Network Pharmacology and RT-qPCR Analysis to Investigate the Mechanisms Underlying ZeXie Decoction-Mediated Treatment of Non-alcoholic Fatty Liver Disease. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.722016
|
| 57 |
Wen Li, Jing Zhou, Yajie Zhang, Jing Zhang, Xue Li, Qiao Yan, Jiabing Han, Fangdi Hu. Echinacoside exerts anti-tumor activity via the miR-503-3p/TGF-β1/Smad aixs in liver cancer. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-01890-3
|
| 58 |
Sirinat Pengnet, Phinsuda Sumarithum, Nuttaphong Phongnu, Sakdina Prommaouan, Napapas Kantip, Ittipon Phoungpetchara, Wachirawadee Malakul. Naringin attenuates fructose-induced NAFLD progression in rats through reducing endogenous triglyceride synthesis and activating the Nrf2/HO-1 pathway. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1049818
|
| 59 |
Yinhua Ni, Liyang Ni, Fen Zhuge, Zhengwei Fu. The Gut Microbiota and Its Metabolites, Novel Targets for Treating and Preventing Non‐Alcoholic Fatty Liver Disease. Molecular Nutrition & Food Research 2020; 64(17) doi: 10.1002/mnfr.202000375
|
| 60 |
Wenxiang Wang, Ce Yang, Jing Xia, Ying Tan, Xiaoyuan Peng, Wei Xiong, Ning Li. Novel insights into the role of quercetin and kaempferol from Carthamus tinctorius L. in the management of nonalcoholic fatty liver disease via NR1H4-mediated pathways. International Immunopharmacology 2024; 143: 113035 doi: 10.1016/j.intimp.2024.113035
|
| 61 |
Jiongshan Zhang, Yue Li, Gemin Xiao, Yongwei Li, Heping Xie, Yan Chen. Fructooligosaccharides enhance the therapeutic effect of xiao-zhi-fang on non-alcoholic fatty liver disease via regulating intestinal flora. Liver Research 2021; 5(4): 217 doi: 10.1016/j.livres.2021.06.003
|
| 62 |
Tianyu Wang, Kairui Sheng, Yifan Zhang, Songlin Jin, Linlin Feng, Lihong Wang. Metabolomics analysis reveals the effect of fermentation on the chemical composition and antioxidant activity of Paeonia lactiflora Root. Heliyon 2024; 10(7): e28450 doi: 10.1016/j.heliyon.2024.e28450
|
| 63 |
Jingying Shi, Yawen Liu, Zijia Zhang, Xianchun Zhong, Yuhan Cao, Hui Ni, Qingqing He, Zhaojun Wang, Yameng Liu, Qinhua Chen, Jianming Wei, Haibo Wang, Likun Gong, Cen Xie, Jinjun Hou, Wanying Wu. Zexie-Baizhu Decoction ameliorates non-alcoholic fatty liver disease through gut-adipose tissue crosstalk. Journal of Ethnopharmacology 2025; 337: 118700 doi: 10.1016/j.jep.2024.118700
|
| 64 |
Ruiting Han, Huihui Qiu, Jing Zhong, Ningning Zheng, Bingbing Li, Ying Hong, Junli Ma, Gaosong Wu, Linlin Chen, Lili Sheng, Houkai Li. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota. Phytomedicine 2021; 85: 153544 doi: 10.1016/j.phymed.2021.153544
|